We are very proud and happy to welcome Novartis at the Frontiers Health Global Hybrid Conference 2020!

Novartis is reimagining medicine to improve and extend people’s lives. While finding innovative ways to expand access to treatments and improve access to healthcare, Novartis products reach nearly 800 million people worldwide. More than 100,000 people of more than 140 nationalities work at Novartis around the world.
Novartis’ strives to provide patients, healthcare professionals and caregivers with safe, effective and efficient care. By following its clear ambition – to be a leading medicines company powered by data and digital – Novartis is open to combine the power of external innovation with industry expertise: to drive medical research and development through the potential of data science, digital technologies and artificial intelligence.

Read more about Novartis and its efforts together with Sandoz Germany in supporting creative minds with the Digital Health Award (Digitaler Gesundheitspreis, submission deadline Nov 30th) (http://www.novartis.de/dgp)

In order to further advance the development of innovative solutions, Novartis is hosting an innovation challenge at Frontiers Health 2020. Startups and innovation-driven companies working on the following topics are invited to participate:

1. How can real world data be accessed and used for advanced research and personalized therapy in cancer?

2. How can nAMD (neovascular age-related macular degeneration) patients, who receive anti-VEGF (vascular endothelial growth factor) drugs, be monitored for ocular inflammation outside of the physician’s office?

The selected startups will be pitching at the virtual session and will get an opportunity to present their solution to a board of Novartis experts. Please find more information about the Call for Applications for Novartis’ innovation challenge here.

Stay tuned to discover more about Novartis at Frontiers Health 2020.